Search

Search Constraints

You searched for: Author/Creator Cicalini, Stefania

Search Results

1. Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice. (September 2022)

2. Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort. (August 2017)

3. Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy. (10th May 2019)

4. COVID‐19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS‐CoV‐2. Issue 3 (8th October 2020)

5. Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV. (19th August 2022)

6. Development and validation of an HPLC‐UV method for quantification of elvitegravir and two other new antiretrovirals, dolutegravir and rilpivirine, in the plasma of HIV‐positive patients. (31st May 2018)

7. Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease. (16th September 2021)

8. High prevalence of intramural coronary infection in patients with drug-resistant cardiac syndrome X: comparison with chronic stable angina and normal controls. Issue 23 (3rd October 2010)